Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. USO
6. AWK
7. GNK
8. ARGX
9. FNGR
10. PLUR

Go back to Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.07 +0.02 (0.25%)
Previous Close $8.05    52 Week High $9.23 
Open $8.05    52 Week Low $1.16 
Day High $8.17    P/E N/A 
Day Low $7.95    EPS $-0.30 
Volume 1,922,855       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.07 +0.02 (0.25%)
Previous Close $8.05    52 Week High $9.23 
Open $8.05    52 Week Low $1.16 
Day High $8.17    P/E N/A 
Day Low $7.95    EPS $-0.30 
Volume 1,922,855